<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2903233447
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE 0.45% SOLU. FOR I.V. INFU. IN VIAFLEX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.45
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        7.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER CO LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 613]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Company Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05CB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        B05XA03
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:28.5pt; margin-right:-.1pt; text-indent:-28.5pt"><!--[if !supportLists]--><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>WHAT SODIUM 0.45 INFUSION IS AND WHAT IT IS USED FOR</strong></p><p>&nbsp;</p><p>Sodium 0.45 Infusion is a solution of sodium chloride in water. Sodium chloride is a chemical substance (often called &ldquo;salt&rdquo;) found in the blood.</p><p>&nbsp;</p><p>Sodium 0.45 Infusion is used to treat:</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a loss of body water, for example after being sick or having diarrhoea (hypertonic extracellular dehydration)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a lower than normal volume of blood in the body (hypovolaemia)</p><p>Sodium 0.45 infusion may also be used to deliver or to dilute other medicines for infusion.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do</strong><strong> NOT receive Sodium 0.45 Infusion if you are suffering from any of the following conditions</strong></p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->lower levels of chloride in the blood than normal (hypochloraemia)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->lower levels of sodium in the blood than normal (hyponatraemia)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->severe kidney problems causing lower than normal or no urine production (oliguria or anuria)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->higher than normal levels of water or sodium in the blood (fluid or sodium retention)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as:</p><p style="margin-left:35.45pt; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->shortness of breath</p><p style="margin-left:35.45pt; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling of the ankles&nbsp;</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->build up of fluid under the skin, affecting all parts of the body (general oedema)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis).</p><p>&nbsp;</p><p>If a medicine has been added to Sodium 0.45 Infusion, the Package Leaflet of the added medicine must be consulted to determine whether or not you can receive the solution.</p><p style="margin-right:-.1pt"><strong>Warnings and precautions</strong></p><p>Please tell your doctor if you have or have had any of the following medical conditions.</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->any type of heart disease or poor heart function</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->poor kidney function</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->respiratory failure (lung disease)</p><p style="margin-left:.25in">(special monitoring may be required in the above conditions)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->raised production of the hormone aldosterone (aldosteronism)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure (hypertension)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure during pregnancy (pre-eclampsia)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->any other condition associated with sodium and fluid retention (when the body retains too much sodium or water), such as treatment with steroids (See also below &ldquo;Taking other medicines&rdquo;).</p><p>&nbsp;</p><p>Some patients are at higher risk for having or developing a too low sodium concentration in your blood (hyponatraemia). In general this applies to young and old people, women and anyone with a condition such as low levels of oxygen in your blood (hypoxemia), drinking a lot due to a dry mouth (psychogenic polydipsia). If you have recently been operated. With certain diseases of the nervous system or when you are taking certain antiepileptic and psychiatric medicines.</p><p style="margin-right:-.1pt"><strong>Other medicines and Sodium 0.45 Infusion</strong></p><p style="margin-right:-.1pt">Please tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.</p><p style="margin-right:-.1pt">&nbsp;</p><p style="margin-right:-.1pt">It is particularly important that you inform your doctor if you are taking:</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->corticosteroids (anti-inflammatory medicines)</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->carbenoxolone (an anti-inflammatory medicine used to treat stomach ulcers)</p><p style="margin-left:21.3pt; margin-right:-.1pt">These medicines can cause the body to accumulate sodium and water, leading to:</p><p style="margin-left:42.55pt; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->tissue swelling due to fluid collection under the skin (oedema)</p><p style="margin-left:42.55pt; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->high blood pressure (hypertension).</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Lithium (used to treat psychiatric illness)</p><p style="margin-right:-.1pt"><strong>Sodium 0.45 Infusion with food and drink</strong></p><p style="margin-right:-.1pt">You should ask your doctor about what you can eat or drink.</p><p style="margin-right:-.1pt">&nbsp;</p><p style="margin-right:-.1pt"><strong>Pregnancy and breast-feeding</strong></p><p style="margin-right:-.1pt">if you are pregnant or breast-feeding, think You may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.</p><p style="margin-right:-.1pt">&nbsp;</p><p>However, if another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should:</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->consult your doctor</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->read the Package Leaflet of the medicine that is to be added.</p><p style="margin-right:-.1pt"><strong>&nbsp;</strong></p><p style="margin-right:-.1pt"><strong>Driving and using machines</strong></p><p>Ask your doctor or nurse for advice before driving or using machines.</p><p>&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:.25in; margin-right:-.1pt">Sodium 0.45 Infusion will be given to you by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, condition, the reason for treatment and whether or not the infusion is being used to deliver or dilute another medicine</p><p style="margin-right:-.1pt">The amount you are given may also be affected by other treatments you are receiving.</p><p style="margin-right:-.1pt"><strong>You should NOT be given Sodium 0.45 Infusion if there are particles floating in the solution or if the pack is damaged in any way.</strong></p><p style="margin-right:-.1pt">Sodium 0.45 Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine.</p><p>When you are given Sodium 0.45 Infusion, your doctor will take blood and urine samples and monitor:</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the amount of fluid in your body</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->your vital signs</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the amount of electrolytes (such as sodium, and chloride) and other chemical substances that are normally in your blood</p><p>This is especially important for children as they have a limited ability to regulate fluids and electrolytes.</p><p style="margin-right:-.1pt">Any unused solution should be thrown away. You should NOT be given an infusion of Sodium 0.45 Infusion from a bag that has been partly used.</p><p style="margin-right:-.1pt"><strong>If you receive more</strong> <strong>Sodium 0.45 Infusion than you should</strong></p><p>If you are given too much Sodium 0.45 Infusion (over-infusion), or it is given too fast, this may lead to the following symptoms:</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->build up of water in the body (oedema)</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->too much water in the blood (haemodilution)</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart problems</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->acidification of the blood (acidosis), leading to tiredness, confusion, lethargy and increased breathing rate.</p><p style="margin-right:-.1pt">If Sodium 0.45 infusion is given too fast when you have higher than normal levels of salts in the blood (hypertonicity), swelling of the brain (brain oedema) is possible, especially if you often have higher than normal levels of sodium in the blood (hypernatraemia).</p><p>If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms.</p><p>If a medicine has been added to your Sodium 0.45 Infusion before over-infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p style="margin-right:-.1pt"><strong>If you stop receiving your Sodium 0.45 Infusion</strong></p><p style="margin-right:-.1pt">Your doctor will decide when to stop giving you this infusion.</p><p style="margin-right:-.1pt">If you have any further questions on the use of this medince, ask your doctor or nurse.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-1.45pt">Like all medicines, Sodium 0.45 Infusion can cause the following side effects, although not everybody gets them.</p><p style="margin-right:-1.45pt">&nbsp;</p><p style="margin-right:-1.45pt">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; too much fluid in the body (overhydration) which may lead to more frequent urination (polyuria)</p><p style="margin-right:-1.45pt">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in the concentrations of the chemicals in the blood (electrolyte disturbances)</p><p style="margin-right:-1.45pt">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart failure, if you suffer from heart disease or fluid in the lungs (pulmonary oedema)</p><p style="margin-left:28.35pt; margin-right:-1.45pt; text-indent:-28.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->low levels of sodium in the blood (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death. Acute hyponatraemic encephalopathy is a serious complication, especially in children, whom have a higher risk for developing symptomatic hyponatraemia.</p><p style="margin-left:.25in; margin-right:-1.45pt">&nbsp;</p><p style="margin-right:-1.45pt">The side effects that may occur due to the administration technique include:</p><p style="margin-left:.25in; margin-right:-.1pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->fever (febrile response)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->infection at the site of infusion</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->local pain or reaction (redness or swelling at the site of infusion)</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused.</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the formation of a blood clot (venous thrombosis) at the site of infusion, which causes pain, swelling or redness in the area of the clot</p><p style="margin-left:.25in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->escape of the infusion solution into the tissues around the vein (extravasation). This can damage the tissues and cause scarring.</p><p>Other side effects noted with similar products (sodium chloride containing solutions) include:</p><p style="margin-left:28.35pt; margin-right:-1.45pt; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Acidification of the blood (hyperchloraemic metabolic acidosis)</p><p style="margin-left:28.35pt; margin-right:-1.45pt; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Reactions with the following symptoms have been reported:</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hives (urticaria) which may be localised to a part of the body or widespread</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->fever (pyrexia)</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->skin rash</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->chills</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->itching (pruritus)</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->decreased blood pressure</p><p style="margin-left:28.35pt; margin-right:-1.45pt; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Other infusion site reactions</p><p style="margin-left:56.7pt; margin-right:-1.45pt; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hives at the infusion site.</p><p>If a medicine has been added to the solution for infusion, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.</p><ul><li>Saudi Arabia:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><table cellspacing="1" cellpadding="0" border="1" style="width:375.0pt"><tbody><tr><td><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>- Please contact the relevant competent authority.</p></td></tr></tbody></table><p style="margin-right:-.1pt">&nbsp;If any side effects occur, the infusion must be stopped.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-.1pt">Keep this medicine out of the sight and reach of children.</p><p>Do not store above 30&deg;C.</p><p style="margin-right:-.1pt">Sodium 0.45 Infusion should NOT be given to you after the expiry date which is stated&nbsp; on the bag after EXP. The expiry date refers to the last day of that month.</p><p style="margin-right:-.1pt">You should not be given Sodium 0.45 Infusion, if there are particles floating in the solution or if the unit is damaged in any way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-.1pt">The active substance is sodium chloride: 4,5 g per litre.</p><p style="margin-right:-.1pt">The only other ingredient is water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Sodium Chloride 0.45% Solution for Infusion is a clear solution, free from visible particles. 
The bags known as VIAFLEX are composed of Plasticised poly (vinyl chloride) plastic bag (PL-146-3). Each bag is wrapped in a sealed, protective, outer plastic overpouch.
The bag size is 500 ml & 1000ml
The bags are supplied in cartons. Each carton contains 26 bags of 500 ml & 16 bags of 1000ml

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-.1pt"><strong>Marketing Authorisation Holder:</strong></p><p>Baxter Company Limited</p><p style="margin-right:-.1pt">&nbsp;Manufacturers:</p><p>Baxter Company Limited</p><p>2nd Industrial Zone Road no 2041</p><p>Dammam, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                FEB. 2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="margin-left:12.6pt; margin-right:5.8pt; text-align:right">الصوديوم 0.45 هو محلول كلوريد الصوديوم داخل الماء، وهو مادة كيميائية (غالباً ما تُسمّى &quot;الملح&quot;) موجودة في الدم.</p><p dir="RTL" style="margin-right:5.8pt; text-align:right">يُستعمل الصوديوم 0.45 من أجل معالجة:</p><p dir="RTL" style="margin-left:37.75pt; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->جفاف الجسم، مثلاً بعد المرض أو بعد الإسهال (جفاف خارج خلوي مفرط)</p><p dir="RTL" style="margin-left:0in; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حجم الدم في الجسم عندما يكون أقلّ من المعدّل الطبيعي (نقص حجم الدم )</p><p dir="RTL" style="margin-left:0in; margin-right:5.8pt; text-align:right">يُمكن استخدام صوديوم 0.45 من أجل حقن أدوية أخرى في الجسم أو تخفيف تركيز دواء تحضيراً لحقنه.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-right:5.8pt; text-align:right"><strong>لا تستخدم الصوديوم 0.45 إذا كنت تعاني أيّاً من الحالات التالية</strong></p><p dir="RTL" style="margin-left:0in; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يكون مستوى الكلوريد في الدم أقلّ من المعدّل الطبيعي</p><p dir="RTL" style="margin-left:0in; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يكون مستوى الصوديوم في الدم أقلّ من المعدّل الطبيعي</p><p dir="RTL" style="margin-left:0in; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مشاكل خطرة في الكلى تتسبّب في قِلّة البَول أو انقطاعه</p><p dir="RTL" style="margin-left:0in; margin-right:23.8pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مستوى الماء أو الصوديوم في الدم أعلى من المعدّل الطبيعي</p><p dir="RTL" style="margin-left:12.15pt; margin-right:23.75pt; text-align:right; text-indent:-17.95pt"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فَشل القلب الغير معوض، أي فشل القلب الذي لم يتم علاجه بشكلٍ كافٍ ويسبّب الأعراض مثل:</p><p dir="RTL" style="margin-left:0in; margin-right:45.15pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الضيق في التنفس</p><p dir="RTL" style="margin-left:0in; margin-right:45.15pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورّم الكاحلين</p><p dir="RTL" style="margin-left:0in; margin-right:23.75pt; text-align:right; text-indent:-17.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->وذمة ورم عامة، تنتشر في كلّ أنحاء الجسم</p><p dir="RTL" style="margin-left:0in; margin-right:23.75pt; text-align:right; text-indent:-17.95pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التليف الكبدي الاستسقائي الذي يُسبّب احتباس السوائل في البطن (تليف الكبد)</p><p dir="RTL" style="margin-left:5.4pt; margin-right:5.75pt; text-align:right">إذا تمت إضافة دواء إلى محلول الصوديوم 0.45، يجب مراجعة النشرة المرفقة بالدواء المُضاف لتحديد ما إذا كان بإمكانك أخذ المحلول.</p><p>تحذيرات واحتياطات</p><p dir="RTL" style="margin-right:5.75pt; text-align:right">أعلم الطبيب إذا كنت تعاني أو عانيت مسبقاً هذه الحالات المرضية.</p><p dir="RTL" style="margin-left:0in; margin-right:23.75pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أيّ نوعٍ من فشل القلب أو ضعف في وظيفة القلب</p><p dir="RTL" style="margin-left:0in; margin-right:26.65pt; text-align:right; text-indent:-20.75pt"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضعف في وظائف الكليتين</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فشل تنفّسي (داء الرئة)</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right">(قد تحتاج إلى مراقبة تحديداً في هذه الحالات المذكورة)</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->زيادة في إنتاج هرمون الألدوستيرون</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عندما يزيد حجم الدم في الأوعية الدموية عن المعدّل الطبيعي</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع في ضغط الدم</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)</p><p dir="RTL" style="margin-left:31.0pt; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أي حالة أخرى مرتبطة بالصوديوم واحتباس السوائل (عندما يحتفظ الجسم بالكثير من الصوديوم أو الماء)، مثل العلاج بالستيرويدات (أنظر قسم &quot;تناول أدوية أخرى&quot; أدناه).</p><p>&nbsp;</p><p dir="RTL" style="margin-left:7.55pt; margin-right:5.85pt; text-align:right">يكون بعض المرضى في خطر مواجهة تراجع نسبة تركيز الصوديوم في الدم (نقص الصوديوم في الدم) أو زيادة نسبته بشكل أكبر من غيرهم. ينطبق هذا الأمر بشكل عام على الشباب المسنّين والنساء وأي شخص يعاني حالة مثل انخفاض مستويات الأكسجين في الدم (نقص تأَكسُج الدم)، ويشرب الكثير من الماء بسبب جفاف الفم (عُطاش نفسي المنشأ)، و الخضوع لعملية جراحية مؤخراً، ومع بعض أمراض الجهاز العصبي أو تناول بعض الأدوية النفسية والمضادة للصرع.</p><p>&nbsp;</p><p>تناولُ أدوية أخرى مع الصوديوم 0.45</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">يجب إعلام الطبيب أو المُمرّضة إذا كنت تتناول أدوية أخرى، أو سبق أن تناولتها مؤخراً أو قد تتناولها قريباً.</p><p>&nbsp;</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">من المهم جداً أن تبلغ الطبيب إذا كنت تتناول:</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كورتيكوستيرويد (أدوية مضّادة للالتهاب)</p><p dir="RTL" style="margin-left:92.7pt; margin-right:27.25pt; text-align:right; text-indent:-21.35pt"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كربينوكسولون (دواء مضّاد للالتهاب يتم تناوله من أجل معالجة قرحات المعدة). قد تسبب هذه الأدوية تراكم نسبة الصوديوم والماء، مما يؤدي إلى:</p><p dir="RTL" style="margin-left:0in; margin-right:48.5pt; text-align:right"><!--[if !supportLists]-->&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورّم الأنسجة بسبب احتباس السوائل تحت البشرة (تورم)</p><p dir="RTL" style="margin-left:0in; margin-right:48.45pt; text-align:right"><!--[if !supportLists]-->&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع في ضغط الدم.</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الليثيوم (يُستخدم من أجل معالجة الأمراض النفسية)</p><p>استخدام الصوديوم 0.45 مع الأكل والشرب</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">يُفضّل أن تراجع الطبيب لمعرفة ما الذي يُسمح لك بتناوله أوشربه</p><p>الحمل والرضاعة الطبيعية</p><p dir="RTL" style="margin-left:4.8pt; margin-right:5.85pt; text-align:right">إذا كنتِ حاملاً أو ترضّعين طبيعياً، أو تعتقدين أنك حامل أو تخططين لتحملي، راجعي الطبيب أو المُمرّضة واطلبي نصيحتهما قبل أن تأخذي هذا الدواء.</p><p dir="RTL" style="margin-left:24.35pt; margin-right:5.85pt; text-align:right">ومع ذلك، إذا توجّب إضافة دواء آخر إلى المحلول الخاص بك للحقن أثناء الحمل أو الرضاعة الطبيعية، يجدر بك:</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مراجعة الطبيب</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قراءة نشرة المريض للدواء المُضاف.</p><p>القيادة واستخدام الآلات</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">استشر الطبيب أو المُمرّضة عن القيادة واستخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:29.75pt; margin-right:23.9pt; text-align:right">يعطيك الطبيب أو المُمرّضة الصوديوم 0.45، وسيقرر الطبيب النسبة التي تحتاج إليها والتوقيت المناسب. يعتمد هذا الأمر على العمر والوزن والحالة، وسبب استخدام الحقنة هذه، وما إذا كان سيتم استخدام الحقنة لتلقي أدوية أخرى إلى الجسم أو مزجها مع المحلول .</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">قد تتأثر نسبة المحلول بحسب العلاجات الأخرى التي تتلقاها.</p><p>يجب ألّا يتم اعطاؤك الصوديوم 0.45 لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال.</p><p dir="RTL" style="margin-left:15.75pt; margin-right:5.9pt; text-align:right">يتم إدخال محلول الصوديوم 0.45 عبر أنبوب بلاستيكي موصول بإبرة يتم إدخالها في الوريد. عادة ما يُستخدم الوريد في ذراعك عند الحقن. ومع ذلك، قد يستخدم الطبيب طريقة أخرى ليعطيك الدواء.</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">عندما يتم إعطاء الصوديوم 0.45، سيأخذ الطبيب عينات من دم وبول ويراقب:</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نسبة السوائل في جسمك</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->علاماتك الحيوية</p><p dir="RTL" style="margin-left:26.4pt; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نسبة الشوارد الكهربائية (على مثال الصوديوم، والكلوريد) والعديد من المواد الكيميائية الأخرى الموجودة عادة في الدم</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">هذا الأمر مهم بشكل خاص للأطفال، حيث أنّ لديهم قدرة محدودة على تنظيم السوائل والشوارد الكهربائية.</p><p dir="RTL" style="margin-left:26.4pt; margin-right:5.9pt; text-align:right">يجب التخلّص من كل محلولٍ لم يتم استخدامه. لا يجب استخدام الصوديوم 0.45 من كيس سبق أن تمّ استخدامه جزئياً.</p><p>في حال تمّ حقن نسبة من صوديوم 0.45 أعلى من المعدّل الطبيعي</p><p dir="RTL" style="margin-left:14.2pt; margin-right:5.9pt; text-align:right"><strong>&nbsp;</strong>في حال تمّ حقن نسبة من صوديوم 0.45 فائضة عن المعدّل الطبيعي، أو تمّ حقن المحلول بسرعة، قد تظهر الأعراض التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:23.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس المياه في الجسم (وذمة)</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نسبة كبيرة جداً من الماء في الدم</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مشاكل في القلب</p><p dir="RTL" style="margin-left:5.05pt; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض قلوية الدم ( احمضاض الدم)، مما قد يسبّب التعب، والارتباك، والخمول وارتفاع معدّل التنفّس.</p><p dir="RTL" style="margin-left:7.3pt; margin-right:5.85pt; text-align:right">إذا أعطي الصوديوم 0.45 بسرعة عندما يكون مستوى الأملاح في الدم أعلى من المعدّل الطبيعي (العضلية)، يكون هناك احتمال للتورم في الدماغ (وذمة الدماغ)، تحديداً إذا كنتَ غالباً ما تعاني ارتفاعاً بنسبة الصوديوم في الدم (فرط صوديوم الدم).</p><p dir="RTL" style="margin-left:12.1pt; margin-right:5.85pt; text-align:right">إذا تطوّرت لديك أي من هذه الأعراض يجب أن تقوم بإبلاغ الطبيب فوراً. سيتم إيقاف الحقنة ومنحك العلاج وفقاً للأعراض.</p><p dir="RTL" style="margin-left:17.65pt; margin-right:5.85pt; text-align:right">إذا أضيف دواء إلى الصوديوم 0.45 قبل حدوث الحقن الزائد، فإنّ هذا الدواء قد يسبب أعراضاً أخرى أيضاً. يجب أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفّر لائحة بالأعراض المُحتملة.</p><p>في حال التوقّف عن أخذ الصوديوم 0.45</p><p dir="RTL" style="margin-right:5.85pt; text-align:right"><strong>&nbsp;</strong>يقرّر الطبيب وقت الانتهاء من أخذ دكستروز.</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">إذا كانت لديك أيّ أسئلة أخرى فلا تتردّد في استشارة الطبيب أو المُمرّضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:15.8pt; margin-right:5.85pt; text-align:right">قد يسبّب الصوديوم 0.45 الآثار الجانبية التالية مثل كافة الأدوية، مع العلم أنّها لا تظهر على كافة الأشخاص.</p><p dir="RTL" style="margin-left:0in; margin-right:34.15pt; text-align:right; text-indent:-28.3pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احتباس كبير في السوائل مما قد يؤدي إلى الفرط بالتبوّل</p><p dir="RTL" style="margin-left:0in; margin-right:34.15pt; text-align:right; text-indent:-28.3pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تغيرات في تركيزات المواد الكيميائية في الدم (اضطرابات في الشوارد الكهربائية)</p><p dir="RTL" style="margin-left:0in; margin-right:34.15pt; text-align:right; text-indent:-28.3pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فشل القلب، إذا كنت تعاني أمراضاً بالقلب أو سوائل في الرئتين (وذمة رئوية)</p><p dir="RTL" style="margin-left:9.95pt; margin-right:34.15pt; text-align:right; text-indent:-28.3pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مستويات منخفضة من الصوديوم في الدم. قد يؤدي نقص الصوديوم في الدم إلى الصداع والغثيان والنوبات والخمول والغيبوبة والتورم في الدماغ والموت. يُعتبر اعتلال الدماغ الحاد بسبب نسبة الصوديوم مضاعفة خطيرة، تحديداً لدى الأطفال الذين يكون خطر زيادة أعراض نقص الصوديوم لديهم أعلى.</p><p dir="RTL" style="margin-right:5.85pt; text-align:right">الآثار الجانبية التي يُحتمل أن تسبّبها تقنية إعطاء دكستروز:</p><p dir="RTL" style="margin-left:0in; margin-right:23.85pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحمى (استجابة حموية)</p><p dir="RTL" style="margin-left:0in; margin-right:28.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انتقال عدوى في موقع الحقن</p><p dir="RTL" style="margin-left:0in; margin-right:28.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم موضعي أو ردّ فعل (احمرار أو تورم في موقع الحقن)</p><p dir="RTL" style="margin-left:14.8pt; margin-right:28.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تهيج والتهاب الوريد الذي تم حقن المحلول فيه، مما يسبب احمراراً، أو ألماً أو حرقاً وتورماً على طول الوريد.</p><p dir="RTL" style="margin-left:8.1pt; margin-right:28.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تشكّل جلطة دموية (تخثر وريدي) في موقع الحقنة، مما يسبب الألم، أو التورم أو الاحمرار في منطقة الجلطة</p><p dir="RTL" style="margin-left:12.55pt; margin-right:28.9pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تسرّب المحلول إلى الأنسجة حول الوريد، مما قد يضرّ بالأنسجة ويتسبب في ندبة.</p><p dir="RTL" style="margin-right:10.9pt; text-align:right">تشمل الآثار الجانبية الأخرى الملاحظة مع منتجات مماثلة (كلوريد الصوديوم الذي يحتوي على المحلول) ما يلي:</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تحمّض الدم (الحماض الأيضي بسبب فرط نسبة الصوديوم)</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تم الإبلاغ عن ردود فعل مع الأعراض التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:67.55pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الشرى التي قد تكون متواجدة في جزء من الجسم أو منتشرة</p><p dir="RTL" style="margin-left:0in; margin-right:67.55pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحمى</p><p dir="RTL" style="margin-left:0in; margin-right:67.55pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الطفح الجلدي</p><p dir="RTL" style="margin-left:0in; margin-right:67.5pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->البرد/ قشعريرة البرد</p><p dir="RTL" style="margin-left:0in; margin-right:67.5pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحُكاك</p><p dir="RTL" style="margin-left:0in; margin-right:67.5pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض ضغط الدم</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ردود فعل أخرى في موقع الحقنة</p><p dir="RTL" style="margin-left:0in; margin-right:67.5pt; text-align:right"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الشرى في موقع الحقنة.</p><p dir="RTL" style="margin-left:5.25pt; margin-right:10.85pt; text-align:justify">إذا تمت إضافة دواء إلى محلول الحقنة، قد يسبب الدواء المُضاف أيضاً آثاراً جانبية. تعتمد الآثار الجانبية هذه على الدواء الذي تمت إضافته. ينبغي أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفر قائمة بالأعراض المحتملة.</p><p dir="RTL" style="margin-right:10.9pt; text-align:right"><strong>الإبلاغ عن آثار جانبية</strong></p><p dir="RTL" style="margin-left:7.95pt; margin-right:10.9pt; text-align:right">إذا لاحظت أي آثارٍ جانبية، تحدّث إلى الطبيب أو الصيدلي أو الممرّضة. يشمل ذلك أيّ آثار جانبية محتملة غير مندرجة ضمن هذه النشرة. يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة عن طريق النظام الوطني للإبلاغ المذكور أدناه. يمكنك بهذه الطريقة أن تساعد على تقديم المزيد من المعلومات عن سلامة استخدام هذا الدواء.</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-10.3pt"><!--[if !supportLists]--></p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:491.3pt"><p dir="RTL" style="margin-left:0in; margin-right:39.05pt; text-align:right; text-indent:0in">&middot;&nbsp;&nbsp; <!--[endif]-->المملكة العربية السعودية:</p><p dir="RTL" style="margin-left:0in; margin-right:39.05pt; text-align:right; text-indent:0in">- المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فاكس: 7662-205-11-966+</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->للاتصال بالمركز الوطني للتيقظ والسلامة الدوائية: 2038222 11 966+، الأرقام الداخلية: 2317 - 2356 - 2353 - 2354 - 2334 - 2340.</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الرقم المجاني: 8002490000</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL" style="margin-left:0in; margin-right:75.05pt; text-align:right"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الموقع: www.sfda.gov.sa/npc</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-10.9pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->دول مجلس التعاون الخليجي الأخرى:</p><p dir="RTL" style="margin-left:0in; margin-right:41.15pt; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُرجى التواصل مع السلطة المختصة ذات الصلة.</p></td></tr></tbody></table><p dir="RTL" style="margin-right:10.9pt; text-align:right">في حال حصول أي آثار جانبية، يجب التوقّف عن استخدام الحقنة.</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-10.3pt">&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:39.2pt; text-align:right; text-indent:-10.3pt">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-right:10.9pt; text-align:right">يُحفظ هذا الدواء بعيداً عن متناول الأطفال.</p><p dir="RTL" style="margin-left:0in; margin-right:5.9pt; text-align:right">يحفظ في درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">لا يجب وصف الصوديوم 0.45 بعد انتهاء تاريخ الصلاحية المطبوع على الكيس بعد كلمة EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL" style="margin-left:11.8pt; margin-right:5.9pt; text-align:right">لا يجدر بك أخذ الصوديوم 0.45 إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:5.9pt; text-align:right">المادة الفعالة هي كلوريد الصوديوم: 4،5 غ لكلّ لتر.</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">المكونات الأخرى الوحيدة هي الماء المُخصّص للحقن، وهيدروكسيد الصوديوم وحمض الهيدروكلوريك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كيف يكون شكل كلوريد الصوديوم 0.45% ومحتويات الكيس</p><p dir="RTL" style="margin-left:4.4pt; margin-right:17.9pt; text-align:right"><strong>&nbsp;</strong>كلوريد الصوديوم 45% هو محلولٌ نقيّ، خالٍ من أيّ جسيمات مرئية. تتألف أكياس Viaflex من كيس من البلاستيك كلوريد الفينيل (PL-146-3). يُغلّف كلّ كيس بغلافٍ خارجي من البلاستيك ممغلف ومحكم الإغلاق.</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">يتوفّر الكيس في حجمين، 500 و1000 مل</p><p dir="RTL" style="margin-right:5.9pt; text-align:right">تُعبأ الأكياس في علب من الكرتون. تحتوي كلّ كرتونة على 26 كيساً 500 مل و16 كيساً 1000 مل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:323.4pt; margin-right:5.9pt; text-align:right"><strong>الشركة الحائزة على ترخيص للتسويق</strong>: شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:323.4pt; margin-right:5.9pt; text-align:right"><strong>الشركة المصنّعة:</strong></p><p dir="RTL" style="margin-left:0in; margin-right:5.9pt; text-align:right">شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:320.35pt; margin-right:5.9pt; text-align:right">المنطقة الصناعية الثانية طريق رقم 2041 الدمام، المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير 2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SODIUM CHLORIDE 0.45% SOLU. FOR I.V. INFU. IN VIAFLEX
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride:                      4.5 g/l
Each ml contains 4.5 mg sodium chloride.
                              Na+                    Cl-
Clmmol/ l                77                   77
mEq/l                      77                    77
154 mOsm/l (approx.)
pH: 4.5 – 7.0
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride 0.45% Solution for Infusion is indicated for the treatment of hypertonic extracellular<br />dehydration or hypovolaemia in cases where the intake of fluids and electrolytes by normal routes is not possible.<br />It can also be used as a vehicle or diluent of compatible medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Posology</u></em><br /><em><u><em>Adults, older people, Adolescents and Children:</em></u></em><br />Fluid balance, serum electrolytes and acid-base balance should be monitored before and during administration, with particular attention to serum sodium in patients with increased non-osmotic<br />vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquired<br />hyponatraemia (see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly important for hypotonic fluids.<br />Sodium Chloride 0.45% Solution for Infusion has a tonicity of 154 mOsm/l (approx.)<br />The infusion rate and volumedepend on age, weight, clinical condition (e.g. burns, surgery, headinjury, infections),and concomitant therapy should be determined by the consulting physician<br />experienced in intravenous fluid therapy (see sections 4.4. and 4.8).<br /><em>Recommended dosage:</em><br />- For adults, older people and adolescents: 500 ml to 3 litres/24h,<br />- For babies and children: 20 to 100 ml per 24 h and per kg of body weight, depending on the age and the total body mass.</p><p>The recommended dosage when used as a vehicle or diluent ranges from 50 to 250 ml per dose of medicinal product to be administered.<br /><em>Administration rate:</em><br />The infusion rate depends on the patient clinical conditions. It is usually:<br />40 ml/kg/24h for adults, older people and adolescents,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - 5 ml/kg/h in average for paediatric patients but the value varies with age:<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - 6-8 ml/kg/h for infants,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - 4-6 ml/kg/h for toddlers,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - 2-4 ml/kg/h for schoolchildren.<br />Note: &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp; Infants and toddlers: age ranges from about 28 days to 23 months (a toddler is an infant who can walk),<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children and schoolchildren: age ranges from about 2 years to 11 years.<br />When Sodium Chloride 0.45% Solution for Infusion is used as a diluent for injectable preparations of other medicinal products, the infusion rate will also be dictated by the nature and the dose regimen of<br />the prescribed medicinal products.<br /><em>Method of Administration:</em></p><p>The solution is for administration by intravenous infusion through a sterile and non-pyrogenic administration set, using aseptic technique. The equipment should be primed with the solution to<br />prevent air entering the system.<br />The product should be inspected visually for particulate matter and discoloration prior to administration. Do not administer unless solution is clear, free from visible particles and the seal is intact.<br />Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of the solution. Administer immediately following the insertion of infusion set.<br />Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container. Pressurizing intravenous solutions contained in flexible<br />plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration. Use of a vented intravenous administration set with the<br />vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.<br />Additives may be introduced before infusion or during infusion through the injection site. Adding other medication or using an incorrect administration technique might cause the appearance of fever<br />reactions due to the possible introduction of pyrogens. If an adverse event occurs the patient evaluated and appropriate countermeasures started. If needed the infusion should be stopped.<br />For information on incompatibilities and preparation of the product with additives, please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The solution is contra-indicated in patient presenting:
- Hyponatraemia, hypochloraemia,
- Extracellular hyperhydration or hypervolaemia,
Severe renal insufficiency (with oliguria/anuria),
Fluid and sodium retention,
Uncompensated cardiac failure,
General oedema and ascitic cirrhosis.
The contra-indications related to the added medicinal product should be considered.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Electrolyte balance</strong><br /><em>Hyponatraemia/Hypernatraemia</em><br />The infusion of solutions with sodium concentrations &lt;0.9% may result in hyponatraemia.<br />High volume infusion must be used under specific monitoring in patients with cardiac or pulmonary failure and in patients with non-osmotic vasopressin release (including SIADH), due to the risk of<br />hospital-acquired hyponatraemia (see below).<br /><em>Hyponatraemia</em><br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, post-operative stress, infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients<br />exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.<br />Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral oedema) characterized by headache, nausea, seizures, lethargy, and vomiting. The risk for hyponatraemia is<br />increased, for example,</p><p>&middot; in children<br />&middot; in elderly patients<br />&middot; in women<br />&middot; in patients with hypoxemia<br />&middot; in patients with underlying central nervous system disease<br />&middot; postoperatively<br />&middot; in persons with psychogenic polydipsia</p><p>in patients treated with medications that increase the risk of hyponatraemia (such as certain antiepileptic and psychotropic medications).<br />Patients with cerebral oedema are at particular risk of severe, irreversible and life-threatening brain injury. Children, women in the fertile age and patients with reduced cerebral compliance (e.g.<br />meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at particular risk of the severe and life-threatening brain swelling caused by acute hyponatraemia.<br />Acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.<br />Hyponatraemia should be corrected at a calculated rate to prevent hyponatraemic encephalopathy.<br />Rapid correction of hyponatraemia and hypernatremia is potentially dangerous (risk of serious neurologic complications). Rapidly correcting hypernatremia once adaptation has occurred may lead<br />to cerebral oedema, potentially resulting in seizures, permanent brain damage, or death.<br />Dosage, rate, and duration of administration should be determined by a physician experienced in intravenous fluid therapy.</p><p><strong>Fluid balance/renal function</strong><br /><em>Use in patients with moderate renal impairment</em><br />The product should be administered with particular caution to patients with moderate renal impairment. In such patients administration of Sodium Chloride 0.45% Solution for Infusion may<br />result in sodium retention.<br /><em>Risk of fluid and/or solute overload and electrolyte disturbances</em><br />Depending on the volume and rate of infusion, intravenous administration of Sodium Chloride 0.45% Solution for Infusion can cause</p><p>&middot; Fluid and/or solute overload resulting in over hydration/hypervolemia and, for example, congested states, including central and peripheral oedema.<br />&middot; Clinically relevant electrolyte disturbances and acid-base imbalance.</p><p>In general; the risk of dilutional states is inversely proportional to the electrolyte concentrations in the solution and additions. The risk of solute overload causing congested states is directly proportional to<br />the electrolyte concentration in the solution and its additions.<br />Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or<br />whenever the condition of the patient or the rate of administration warrants such evaluation.<br /><em>Use in patients at risk for sodium retention, fluid overload and oedema</em><br />Sodium Chloride 0.45% Solution for Infusion should be used with particular caution, if at all, in patients with or at risk for:</p><p>&middot; Hypervolemia<br />&middot; Conditions that may cause sodium retention, fluid overload and oedema (central and peripheral), such as patients with<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - primary hyperaldosteronism,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - secondary hyperaldosteronism associated with, for example,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - hypertension,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - congestive heart failure,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - liver disease (including cirrhosis),<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - renal disease (including renal artery stenosis, nephrosclerosis) or<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - pre-eclampsia.<br />Medications that may increase the risk of sodium and fluid retention, such as corticosteroids.</p><p>I<em>nfusion reactions</em><br />Symptoms of unknown aetiology which can appear to be hypersensitivity reactions have been reported very rarely in association with parenteral infusion of Sodium Chloride. These have been characterized<br />as hypotension, pyrexia, tremor, chills, urticaria, rash and pruritus. Stop the infusion immediately if signs or symptoms of these reactions develop. Appropriate therapeutic countermeasures should be<br />instituted as clinically indicated.</p><p><strong>Specific patient groups</strong><br />The consulting physician should be experienced in this product&rsquo;s use and safety in these special populations that are especially sensitive to rapid changes in serum sodium levels.<br />Rapid correction of hyponatraemia and hypernatremia is potentially dangerous (risk of serious neurologic complications). see section &ldquo;Hyponatraemia/hypernatraemia&rdquo; above.<br /><em>Paediatric population</em><br />Plasma electrolyte concentrations should be closely monitored in the paediatric population as this population may have impaired ability to regulate fluids and electrolytes. Repeated infusions of sodium<br />chloride should only be given after determination of serum sodium level.<br />The infusion of hypotonic fluids together with the non-osmotic secretion of ADH may result in hyponatraemia. Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral<br />oedema and death, therefore acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.<br /><em>Geriatric population</em><br />In older people, the risk for hyponatraemia is increased. When selecting the type of infusion solution and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally<br />more likely to have cardiac, renal, hepatic, and other diseases or concomitant drug therapy.</p><p><strong>Other warnings</strong><br /><em>Osmolarity</em><br />Sodium Chloride 0.45% Solution for Infusion is hypotonic with an osmolarity of approximately 154 mOsmol/L.<br />Administration with blood products<br />Do not mix or administer Sodium Chloride 0.45% Solution for Infusion through the same administration set with whole blood or cellular blood components.<br />During long-term infusion, the doctor can decide to give you an appropriate nutritive supply.<br />As with all parenteral solutions, compatibilities should be checked when additives are used (see section 6.2).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Interaction related to the presence of sodium:</u><br />Corticoids/Steroids and carbenoxolone, which are associated with the retention of sodium and water<br />(with oedema and hypertension), see section 4.4 special warnings and precautions for use.</p><p>Drugs leading to an increased vasopressin effect:<br />The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free water excretion and may increase the risk of hospital acquired hyponatraemia following inappropriately<br />balanced treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).<br />&middot; Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate, carbamazepine,&nbsp; vincristine, selective serotonin reuptake inhibitors, 3.4-methylenedioxy-N-methamphetamine,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ifosfamide, antipsychotics, narcotics<br />&middot; Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, cyclophosphamide<br />&middot; Vasopressin analogues include: Desmopressin, oxytocin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include diuretics in general and antiepileptics such as oxcarbazepine.</p><p>Caution is advised in patients treated with lithium. Renal sodium and lithium clearance may be decreased in the presence of hyponatraemia. Administration of Sodium Chloride 0.45% Solution for<br />Infusion may result in increased lithium levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no adequate data from the use Sodium Chloride 0.45% Solution for Infusion in pregnant or lactating women. The physician should carefully consider the potential risks and benefits for each<br />specific patient before administering Sodium Chloride 0.45% Solution.<br />Sodium Chloride 0.45% Solution for Infusion should be administrated with special caution for pregnant women during labour particularly as to serum-sodium if administered in combination with<br />oxytocin (see section 4.4, 4.5 and 4.8).<br />When a medicinal product is added, the nature of the drug and its use during pregnancy and lactation have to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of Sodium Chloride 0.45% Solution for Infusion on the ability<br />to operate an automobile or other heavy machinery</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>the following undesirable effects have been reported to have occurred during or following infusion of Sodium Chloride 0.45% Solution for Infusion.</p><table cellspacing="1" cellpadding="0" border="1" style="width:375.0pt"><tbody><tr><td style="width:183.75pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; System Organ Class</p></td><td style="width:189.75pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptoms (LLT terme MedDRA) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></td></tr><tr><td style="width:183.75pt"><p>Metabolism and nutrition disorders</p></td><td style="width:189.75pt"><p>Overhydration* (associated or not with polyuria) in<br />patients with cardiac disorder or pulmonary oedema<br />Asymptomatic electrolyte disturbance<br />Hyponatraemia<br />Hospital acquired hyponatraemia**</p></td></tr><tr><td style="width:183.75pt"><p>Nervous system disorders</p></td><td style="width:189.75pt"><p>Acute hyponatraemic encephalopathy**</p></td></tr><tr><td style="width:183.75pt"><p>Cardiac disorders</p></td><td style="width:189.75pt"><p>Heart failure in patients with cardiac disorder or pulmonary oedema</p></td></tr><tr><td style="width:183.75pt"><p>Vascular disorders</p></td><td style="width:189.75pt"><p>Thrombophlebitis*<br />Venous thrombosis*</p></td></tr><tr><td style="width:183.75pt"><p>General disorders and administration site conditions</p></td><td style="width:189.75pt"><p>Fever*<br />Injection site pain*<br />Injection site reaction*<br />Injection site phlebitis*<br />Injection site irritation*<br />Injection site infection*<br />Extravasation*</p></td></tr></tbody></table><p>The frequency of the adverse drug reactions listed in this section cannot be estimated from the available data<br />* Adverse reactions associated with the technique of administration<br />**Hospital acquired hyponatraemia may cause irreversible brain injury and death, due to development of acute hyponatraemic<br />encephalopathy, frequency unknown (see sections 4.2. 4.4, 4.5).<br />The following adverse reactions have not been reported with this product but may occur:<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &middot; Hyperchloraemic metabolic acidosis<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &middot; Infusion reactions, including hypotension, tremor, chills, urticaria, rash, and pruritus.</p><p>Adverse reactions may be associated to the medicinal products added to the solution; the nature of the<br />additive will determine the likelihood of any other undesirable effects.<br />If an adverse event occurs the patient should be evaluated and appropriate countermeasures started, if<br />needed the infusion should be stopped<br /><em>Reporting of suspected adverse reactions</em><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It<br />allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare<br />professionals are asked to report any suspected adverse reactions via:<br />&middot; Saudi Arabia:</p><table cellspacing="1" cellpadding="0" border="1" style="width:375.0pt"><tbody><tr><td><p>&bull; Saudi Arabia:</p><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>- Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume of Sodium Chloride 0.45% Solution for Infusion may lead to:<br /> hypo- and hypernatremia (which can lead to CNS manifestations, including seizures, coma, cerebral oedema and death) and<br /> sodium overload (which can lead to central and/or peripheral oedema).<br />See also section 4.4.<br />Excessive administration of chloride salts may cause a loss of bicarbonate with an acidifying effect.<br />When Sodium Chloride 0.45% Solution for Infusion is used as a diluent for injectable preparations of<br />other medicinal products, the signs and symptoms of over infusion will be related to the nature of the<br />additives being used.<br />In the event of accidental over infusion, treatment should be discontinued and the patient should be<br />observed for the appropriate signs and symptoms related to the drug administered. The relevant and<br />supportive measures should be provided as necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group &ldquo;Electrolyte solutions&rdquo;, ATC code B05XA03.<br />Sodium Chloride 0.45% Solution for Infusion is a hypotonic solution, with an approximate osmolarity of 154 mOsm/l.<br />The pharmacodynamic properties of the solution are those of the sodium and chloride ions in<br />maintaining the fluid and electrolyte balance. Ions, such as sodium, circulate through the cell<br />membrane, using various mechanisms of transport, among which is the sodium pump (Na-K-ATPase).<br />Sodium plays an important role in neurotransmission and cardiac electrophysiology, and also in renal function.</p><p>Chloride is mainly an extracellular anion. Intracellular chloride is in high concentration in red blood<br />cells and gastric mucosa. Reabsorption of chloride follows reabsorption of sodium.<br />When medication is added to Sodium Chloride 0.45% Solution for Infusion, the overall<br />pharmacodynamics of the solution will depend on the nature of the medicinal product used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium and Chloride are mainly distributed in blood and extracellular compartiments (Na+: 142 mmol/l &ndash; Cl-: 103 mmol/l).<br />Sodium is predominantly excreted by the kidney with a renal reabsorption.<br />Small amounts of sodium are lost in the faeces and sweat at the skin level.<br />When medication is added to Sodium Chloride 0.45% Solution for Infusion, the overall<br />pharmacokinetics of the solution will depend on the nature of the medicinal product used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of this solution for infusion in animals are not relevant since its constituents are<br />physiological components of animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections.<br />Sodium hydroxide.<br />Hydrochloric acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibility of the medicinal product to be added to the solution in Viaflex container must be assessed before addition. Those additives known to be incompatible should not be used.<br />In the absence of compatibility studies, this solution must not be mixed with other medicinal productsSee section 6.6 for further instructions on the use of the product with additives</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                500 ml bags: 24Months
1000 ml bags: 24Months
In-use shelf-life:           From a microbiological point of view, the diluted product must be used
                                        immediately. If not used immediately, in-use storage times and conditions
                                       prior to use are the responsibility of the user and would normally not be longer
                                       than 24 hours at 2 to 8°C unless reconstitution has taken place in controlled and validated aseptic conditions.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bag size: 500 ml &amp; 1000ml<br />The bags known as Viaflex are composed of Plasticised poly (vinyl chloride) plastic bag (PL- 146-3).<br />The bags are overwrapped with a protective plastic overpouch.<br />Outer carton contents: 26 bags of 500 ml &amp; 16 bags of 1000ml</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Please see section 4.2 for information regarding the method of administration.<br />Before adding a drug, verify it is soluble and stable in water at the pH range of the Sodium Chloride 0.45% Solution for Infusion (pH 4.5 to 7.0). Additives may be introduced before infusion or during<br />infusion through the injection site.<br />It is the responsibility of the healthcare professional to judge the incompatibility of an additive medication with the Sodium Chloride 0.45% Solution for Infusion, by checking for eventual colour<br />change and/or eventual appearance of precipitate, insoluble complexes or crystals. The instruction for use of the medicinal product to be added must be consulted.<br />When additive is used, verify isotonicity prior to parenteral administration. Thorough and careful aseptic mixing of any additive is mandatory. Solutions containing additives should be used<br />immediately and not stored.</p><p><strong>Discard after single use.</strong><br /><strong><strong>Discard any unused portion.</strong><br /><strong>Do not reconnect partially used bags.</strong><br /><strong>Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of the product.</strong></strong></p><p><u>1. Opening</u><br />a. Remove the Viaflex container from the overpouch just before use.<br />b. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution, as sterility may be broken.<br />c. Check the solution for clarity and absence of foreign matters. If solution is not clear or contains foreign matters, discard the solution.</p><p><u>2. Preparation for administration</u><br />Use sterile material for preparation and administration.<br />a. Suspend container from eyelet support.<br />b. Remove plastic protector from outlet port at bottom of container:<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - grip the small wing on the neck of the port with one hand,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - grip the large wing on the cap with the other hand and twist,<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - the cap will pop off.<br />c. Use an aseptic method to set up the infusion.<br />d. Attach administration set. Refer to complete directions accompanying set for connection, priming of the set and administration of the solution.</p><p><u>3. Techniques for injection of additive medications</u><br /><em>Warning: Additives may be incompatible.</em><br /><em><em>To add medication before administration</em></em><br />a. Disinfect medication site.<br />b. Using syringe with 19 (1.10 mm) to 22 (0.70 mm) gauge needle, puncture resealable medication<br />&nbsp;&nbsp;&nbsp; port and inject.<br />c. Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</p><p><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Caution: Do not store bags containing added medications.</p><p>&nbsp;</p><p><em>To add medication during administration</em><br />a. Close clamp on the set.<br />b. Disinfect medication site.<br />c. Using syringe with 19 (1.10 mm) to 22 (0.70 mm) gauge needle, puncture resealable medication port and inject.<br />d. Remove container from IV pole and/or turn to an upright position.<br />e. Evacuate both ports by tapping gently while the container is in an upright position.<br />f. Mix solution and medication thoroughly.<br />g. Return container to in use position, re-open the clamp and continue administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Company Limited
2nd Industrial Zone Road no 2041
Dammam, Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                30 NOV. 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>